Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

TXNDC17 Protein

This Recombinant TXNDC17 protein is produced in Escherichia coli (E. coli).
Catalog No. ABIN7198224

Quick Overview for TXNDC17 Protein (ABIN7198224)

Target

See all TXNDC17 Proteins
TXNDC17 (Thioredoxin Domain Containing 17 (TXNDC17))

Protein Type

Recombinant

Origin

  • 3
  • 1
  • 1
Human

Source

  • 2
  • 2
  • 1
Escherichia coli (E. coli)

Purity

> 97 % as determined by reducing SDS-PAGE.
  • Purpose

    Recombinant Human TXNDC17/TRP14/TXNL5 Protein

    Sequence

    Met 1-Asp 123

    Characteristics

    A DNA sequence encoding the mature form of human TXNDC17 (Q9BRA2) (Met 1-Asp 123) was expressed and purified, with an initial Met.
  • Want other Options for this Protein ?

    !
    Discover Our Predefined Custom Proteins and Custom Protein Services!

    Your project requires further customization? Contact us and discover our custom protein solutions

  • Restrictions

    For Research Use only
  • Format

    Lyophilized

    Reconstitution

    Please refer to the printed manual for detailed information.

    Buffer

    Lyophilized from sterile PBS, pH 7.4

    Storage

    4 °C,-20 °C,-80 °C

    Storage Comment

    Generally, lyophilized proteins are stable for up to 12 months when stored at -20 to -80°C. Reconstituted protein solution can be stored at 4-8°C for 2-7 days. Aliquots of reconstituted samples are stable at < -20°C for 3 months.
  • Target

    TXNDC17 (Thioredoxin Domain Containing 17 (TXNDC17))

    Alternative Name

    TXNDC17//TXNL5

    Background

    Background: Cell surface A33 antigen, also known as glycoprotein A33, is a single-pass type I  membrane protein which is expressed in normal gastrointestinal epithelium and in 95% of colon cancers. GPA33 contains one Ig-like C2-type (immunoglobulin-like) domain and one Ig-like V-type (immunoglobulin-like) domain. The open reading frame encodes a 319-amino acid polypeptide having a putative secretory signal sequence and 3 potential glycosylation sites. The predicted mature protein has a 213-amino acid extracellular region, a single transmembrane domain, and a 62-amino acid intracellular tail. Intracellular traffic and recycling to the cell surface appear to play a major role in GPA33 function and to have an influence on its surface density superseding translational regulation. GPA33 has become a promising target of immunologic therapy strategies, but its biologic function and potential role in tumorigenesis are unknown. EpCAM protein and GPA33 mRNA expressions are specific and sensitive markers of Barrett's metaplasia (BM). GPA33 may also play a role in cell-cell recognition and signaling.Immune Checkpoint   Immunotherapy   Cancer Immunotherapy   Targeted Therapy

    Synonym: TRP14;TXNL5

    Molecular Weight

    13.9 kDa

    UniProt

    Q9BRA2
You are here:
Chat with us!